Literature DB >> 25368906

Elevated Expression of Nrf-2 and ABCG2 Involved in Multi-drug Resistance of Lung Cancer SP Cells.

B Yang1, Y-F Ma1, Y Liu1.   

Abstract

BACKGROUND: Over expression of ATP-binding cassette (ABC) transporter protein (ABCG2) in side population cells plays a crucial role in the chemotherapeutic drug efflux. Constitutive expression of redox sensing transcritption factor Nrf2 was shown to be involved in regulation of ABCG2 expression and chemoresistance. In the current study we made an attempt to characterize the lung adenocarcinoma SP cells.
MATERIALS AND METHODS: We used FACs based Hoechst 33342 dye exclusion assay for purification of lung cancer SP cells. The sorted SP cells were subjected to drug resistance, sphere formation assays and gene expression analysis (Nrf2 and ABCG2).
RESULTS: We have identified 2.9% of SP cells from lung cancer whose prevalence is significantly reduced to 0.3% upon treatment with verapamil. RT-PCR and western blot analysis revealed that Nrf2 and ABCG2 were highly expressed in lung cancer SP cells. Further, these SP cells are resistant to several chemotherapeutic drugs, self-renewal, and highly tumorigenic than non-SP cells.
CONCLUSIONS: Our data suggest that Nrf2-mediated ABCG2 over expression in lung adenocarcinoma SP cells might responsible for chemotherapy failure. Therefore, designing novel anticancer drugs that attenuates the Nrf2 and ABCG2 expression, makes SP cells more sensitive to chemotherapy and thus prevent the tumor relapse. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25368906     DOI: 10.1055/s-0034-1390458

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  10 in total

1.  Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

Authors:  Ning Ji; Yuqi Yang; Chao-Yun Cai; Zi-Ning Lei; Jing-Quan Wang; Pranav Gupta; Suneet Shukla; Suresh V Ambudkar; Dexin Kong; Zhe-Sheng Chen
Journal:  Cancer Lett       Date:  2018-10-10       Impact factor: 8.679

2.  Involvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres.

Authors:  In-Geun Ryoo; Geon Kim; Bo-Hyun Choi; Sang-Hwan Lee; Mi-Kyoung Kwak
Journal:  Biomol Ther (Seoul)       Date:  2016-09-01       Impact factor: 4.634

Review 3.  Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.

Authors:  In-geun Ryoo; Sang-hwan Lee; Mi-Kyoung Kwak
Journal:  Oxid Med Cell Longev       Date:  2015-11-22       Impact factor: 6.543

4.  NRF2 Is a Potential Modulator of Hyperresistance to Arsenic Toxicity in Stem-Like Keratinocytes.

Authors:  Xiafang Wu; Bei Yang; Yuxin Hu; Ru Sun; Huihui Wang; Jingqi Fu; Yongyong Hou; Jingbo Pi; Yuanyuan Xu
Journal:  Oxid Med Cell Longev       Date:  2017-09-10       Impact factor: 6.543

5.  Elevated expression of Nrf2 mediates multidrug resistance in CD133+ head and neck squamous cell carcinoma stem cells.

Authors:  Bao-Cai Lu; Jing Li; Wen-Fa Yu; Guo-Zheng Zhang; Hui-Min Wang; Hui-Min Ma
Journal:  Oncol Lett       Date:  2016-10-17       Impact factor: 2.967

6.  VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.

Authors:  Ning Ji; Yuqi Yang; Chao-Yun Cai; Zi-Ning Lei; Jing-Quan Wang; Pranav Gupta; Qiu-Xu Teng; Zhe-Sheng Chen; Dexin Kong; Dong-Hua Yang
Journal:  Front Pharmacol       Date:  2018-10-30       Impact factor: 5.810

7.  Anlotinib suppresses metastasis and multidrug resistance via dual blockade of MET/ABCB1 in colorectal carcinoma cells.

Authors:  Lin-Hai Yan; Di Zhang; Si-Si Mo; Hao Yuan; Xian-Wei Mo; Jin-Min Zhao
Journal:  J Cancer       Date:  2021-02-16       Impact factor: 4.207

8.  Identification of side population cells in human lung adenocarcinoma A549 cell line and elucidation of the underlying roles in lung cancer.

Authors:  Tong Xie; Lingzhao Mo; Li Li; Naiquan Mao; Danrong Li; Deseng Liu; Chuantian Zuo; Dingming Huang; Qi Pan; Li Yang; Shoufeng Wang
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

9.  Changes of KEAP1/NRF2 and IKB/NF-κB Expression Levels Induced by Cell-Free DNA in Different Cell Types.

Authors:  Svetlana V Kostyuk; Lev N Porokhovnik; Elizaveta S Ershova; Elena M Malinovskaya; Marina S Konkova; Larisa V Kameneva; Olga A Dolgikh; Vladimir P Veiko; Vladimir M Pisarev; Andrew V Martynov; Vasilina A Sergeeva; Andrew A Kaliyanov; Anton D Filev; Julia M Chudakova; Margarita S Abramova; Serguey I Kutsev; Vera L Izhevskaya; Nataliya N Veiko
Journal:  Oxid Med Cell Longev       Date:  2018-03-20       Impact factor: 6.543

Review 10.  Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight.

Authors:  Lourdes Cortes-Dericks; Domenico Galetta
Journal:  Cancers (Basel)       Date:  2022-01-06       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.